Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bio-America
Acquisition of Novocure completed
June 26th, 2004
Bio-America (BOAI) announced that it has completed the acquisition of all of the issued and outstanding shares of a private biotechnology company, Novocure, Inc., in exchange for 4.2 million shares of Bio-America, Inc. Novocure is a private company that holds the intellectual property rights and trademarks in the biotechnological innovations of Eliezer Huberman, who is recognized as one of the world's leading cellular and molecular biologists. Effective immediately, Huberman has been appointed to head the scientific advisory board of Bio-America. Huberman is currently group leader & senior biologist at the Argonne National Laboratory. Argonne was the...
Source: Law & Health Weekly (2004-06-26)
|
